As of 2024-12-12, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -0.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is 51.73 mil USD. FBIO's TTM EBITDA according to its financial statements is -101.97 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 15.2x | 13.9x |
| Forward P/E multiples | 15.7x - 21.4x | 15.8x |
| Fair Price | (57.96) - (55.82) | (54.68) |
| Upside | -2913.8% - -2809.8% | -2754.2% |
| Date | EV/EBITDA |
| 2024-12-11 | -0.53 |
| 2024-12-10 | -0.52 |
| 2024-12-09 | -0.56 |
| 2024-12-06 | -0.50 |
| 2024-12-05 | -0.51 |
| 2024-12-04 | -0.54 |
| 2024-12-03 | -0.54 |
| 2024-12-02 | -0.57 |
| 2024-11-29 | -0.53 |
| 2024-11-27 | -0.45 |
| 2024-11-26 | -0.45 |
| 2024-11-25 | -0.40 |
| 2024-11-22 | -0.39 |
| 2024-11-21 | -0.37 |
| 2024-11-20 | -0.37 |
| 2024-11-19 | -0.38 |
| 2024-11-18 | -0.35 |
| 2024-11-15 | -0.34 |
| 2024-11-14 | -0.37 |
| 2024-11-13 | -0.40 |
| 2024-11-12 | -0.41 |
| 2024-11-11 | -0.43 |
| 2024-11-08 | -0.41 |
| 2024-11-07 | -0.42 |
| 2024-11-06 | -0.43 |
| 2024-11-05 | -0.43 |
| 2024-11-04 | -0.42 |
| 2024-11-01 | -0.46 |
| 2024-10-31 | -0.46 |
| 2024-10-30 | -0.47 |
| 2024-10-29 | -0.50 |
| 2024-10-28 | -0.50 |
| 2024-10-25 | -0.45 |
| 2024-10-24 | -0.42 |
| 2024-10-23 | -0.43 |
| 2024-10-22 | -0.44 |
| 2024-10-21 | -0.43 |
| 2024-10-18 | -0.45 |
| 2024-10-17 | -0.44 |
| 2024-10-16 | -0.42 |
| 2024-10-15 | -0.42 |
| 2024-10-14 | -0.40 |
| 2024-10-11 | -0.39 |
| 2024-10-10 | -0.38 |
| 2024-10-09 | -0.38 |
| 2024-10-08 | -0.36 |
| 2024-10-07 | -0.38 |
| 2024-10-04 | -0.39 |
| 2024-10-03 | -0.39 |
| 2024-10-02 | -0.37 |